Article Impact Level: HIGH Data Quality: STRONG Summary of Neuro-Oncology https://doi.org/10.1093/neuonc/noaf242 Dr. Akifumi Hagiwara et al.
Points
- A new study suggests that disruptions in the brain’s fluid flow system predict survival in glioblastoma patients.
- Researchers used advanced MRI techniques to measure fluid movement in brain regions far from the tumor.
- Impaired fluid circulation, indicated by specific MRI markers, was strongly linked to shorter overall patient survival.
- This discovery suggests that glioblastoma affects the entire brain environment, not just the localized tumor area.
- These imaging markers could lead to personalized treatment plans and therapies aimed at improving brain fluid dynamics.
Summary
This study investigated the prognostic relevance of glymphatic dysfunction and neurofluid dynamic alterations in patients with isocitrate dehydrogenase (IDH) wild-type glioblastoma (GBM). Researchers retrospectively analyzed preoperative MRI data from 546 patients across two cohorts (UPENN-GBM, n=277; UCSF-PDGM, n=269). They quantified the ALPS (Diffusion Tensor Imaging analysis along the Perivascular Space) index and Free Water (FW) volume fraction in both tumor regions and normal-appearing white matter (NAWM) in both hemispheres. Data harmonization was performed using ComBat to adjust for intersite variability.
The ALPS index was significantly lower in tumor regions compared to NAWM (P < .01). Importantly, in the contralateral hemisphere’s NAWM, a lower ALPS index and higher FW were independently associated with shorter overall survival (HR = 0.75, P = .027 for ALPS index; HR = 1.34, P = .04 for FW). These findings suggest that neurofluid dynamic disturbances extend beyond the immediate tumor vicinity and hold significant prognostic value.
Optimal ALPS index and FW thresholds, derived from the UPENN-GBM dataset, successfully stratified survival and were validated in the UCSF-PDGM cohort (P = .011 for ALPS; P = .038 for FW). These results support the utilization of DTI-ALPS and FW imaging as noninvasive biomarkers for prognostic stratification in IDH wild-type GBM patients. Furthermore, these findings open new avenues for therapeutic targeting aimed at improving glymphatic function, potentially complementing existing cancer therapies and extending survival.
Link to the article: https://academic.oup.com/neuro-oncology/advance-article/doi/10.1093/neuonc/noaf242/8283560?login=false
References
Hagiwara, A., Uchida, W., Ozawa, T., Takabayashi, K., Zou, R., Ellingson, B. M., Andica, C., Kikuta, J., Akashi, T., Wada, A., Kumamaru, K. K., Kamagata, K., Akiyama, O., Kondo, A., & Aoki, S. (2025). Contralateral neurofluid dynamics predict survival in idh wild-type glioblastoma: A dti-alps and free water imaging study. Neuro-Oncology, noaf242. https://doi.org/10.1093/neuonc/noaf242
